Background
Babesia
, a tick-borne genus of intraerythrocytic parasites, is understudied in humans outside of established high-endemic areas. There is a paucity of data on
Babesia
in Africa, despite evidence that it is regionally present. A pilot study suggested that
Babesia
was present in a rural district of Tanzania.
Methodology/Principal findings
A cross-sectional study was conducted July-August 2017: residents in a case hamlet that had clustering of subjects with high signal-to-cut off (S/CO) ratios for antibodies against
B
.
microti
in the pilot study, and a control hamlet that had lacked significant signal, were evaluated for
B
.
microti
. Subjects aged ≥15yrs (n = 299) underwent clinical evaluation and household inspections; 10ml whole blood was drawn for
Babesia
transcription mediated amplification (TMA),
B
.
microti
indirect fluorescent antibody testing (IFA) and rapid diagnostic testing (RDT) for
Plasmodium
spp. Subjects aged <15yrs (n = 266) underwent a RDT for
Plasmodium
and assessment by ELISA for
B
.
microti
antibodies. A total of 570 subjects participated (mean age 22 [<1 to 90yrs]) of whom 50.7% were female and 145 (25.5%) subjects were
Plasmodium
RDT positive (+). In those <15yrs, the median ELISA S/CO was 1.11 (IQR 0.80–1.48); the median S/CO in the case (n = 120) and control (n = 146) hamlets was 1.19 (IQR 0.81–1.48) and 1.06 (IQR 0.80–1.50) respectively (p = 0.4). Children ≥5yrs old were more likely to have a higher S/CO ratio than those <5yrs old (p<0.001). One hundred (38%) subjects <15yrs were
Plasmodium
RDT+. The median S/CO ratio (children <15yrs) did not differ by RDT status (p = 0.15). In subjects ≥15yrs, no molecular test was positive for
Babesia
, but four subjects (1.4%) were IFA reactive (two each at titers of 128 and 256).
Conclusions/Significance
The findings offer further support for
Babesia
in rural Tanzania. However, low prevalence of seroreactivity questions its clinical significance.